ALNYLAM PHARMACEUTICALS, INC. Quarterly Common Stock, Shares, Issued from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Alnylam Pharmaceuticals, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q2 2010 to Q3 2024.
  • Alnylam Pharmaceuticals, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 129M shares, a 2.7% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 129M +3.39M +2.7% Sep 30, 2024 10-Q 2024-10-31
Q2 2024 128M +3.12M +2.5% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 126M +2.22M +1.79% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 126M +1.87M +1.51% Dec 31, 2023 10-Q 2024-10-31
Q3 2023 125M +2.46M +2% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 125M +3.91M +3.23% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 124M +3.51M +2.91% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 124M +3.74M +3.11% Dec 31, 2022 10-K 2024-02-15
Q3 2022 123M +3.51M +2.94% Sep 30, 2022 10-Q 2022-10-27
Q2 2022 121M +2.4M +2.02% Jun 30, 2022 10-Q 2022-07-28
Q1 2022 121M +3.41M +2.91% Mar 31, 2022 10-Q 2022-04-28
Q4 2021 120M +3.76M +3.23% Dec 31, 2021 10-K 2023-02-23
Q3 2021 119M +3.34M +2.87% Sep 30, 2021 10-Q 2021-10-28
Q2 2021 119M +2.95M +2.55% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 117M +4.15M +3.67% Mar 31, 2021 10-Q 2021-04-29
Q4 2020 116M +4.24M +3.78% Dec 31, 2020 10-K 2022-02-10
Q3 2020 116M +4.82M +4.33% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 116M +4.53M +4.08% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 113M +6.77M +6.36% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 112M +11M +10.9% Dec 31, 2019 10-K 2021-02-11
Q3 2019 111M +10.4M +10.3% Sep 30, 2019 10-Q 2019-10-31
Q2 2019 111M +10.5M +10.5% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 106M +5.93M +5.9% Mar 31, 2019 10-Q 2019-05-02
Q4 2018 101M +1.51M +1.52% Dec 31, 2018 10-K 2020-02-13
Q3 2018 101M +8.6M +9.31% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 101M +8.87M +9.67% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 100M +14.4M +16.7% Mar 31, 2018 10-Q 2018-05-04
Q4 2017 99.7M +13.7M +16% Dec 31, 2017 10-K 2019-02-14
Q3 2017 92.4M +6.6M +7.7% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 91.7M +6.13M +7.16% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 86.1M +605K +0.71% Mar 31, 2017 10-Q 2017-05-05
Q4 2016 85.9M +850K +1% Dec 31, 2016 10-K 2018-02-15
Q3 2016 85.8M +1.06M +1.25% Sep 30, 2016 10-Q 2016-11-03
Q2 2016 85.6M +1.04M +1.23% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 85.5M +1.25M +1.48% Mar 31, 2016 10-Q 2016-05-04
Q4 2015 85.1M +7.89M +10.2% Dec 31, 2015 10-K 2017-02-15
Q3 2015 84.7M +8.03M +10.5% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 84.5M +8.21M +10.8% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 84.2M +8.73M +11.6% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 77.2M +13.5M +21.1% Dec 31, 2014 10-K 2016-02-12
Q3 2014 76.7M +13.4M +21.3% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 76.3M +13.9M +22.2% Jun 30, 2014 10-Q 2014-08-08
Q1 2014 75.5M +13.4M +21.5% Mar 31, 2014 10-Q 2014-05-09
Q4 2013 63.7M +11.3M +21.4% Dec 31, 2013 10-K 2015-02-13
Q3 2013 63.2M +10.9M +20.7% Sep 30, 2013 10-Q 2013-11-07
Q2 2013 62.5M +10.5M +20.1% Jun 30, 2013 10-Q 2013-08-09
Q1 2013 62.1M +10.2M +19.7% Mar 31, 2013 10-Q 2013-05-07
Q4 2012 52.5M +9.77M +22.9% Dec 31, 2012 10-K 2014-02-20
Q3 2012 52.4M +9.69M +22.7% Sep 30, 2012 10-Q 2012-11-05
Q2 2012 52M +9.34M +21.9% Jun 30, 2012 10-Q 2012-08-08
Q1 2012 51.9M +9.53M +22.5% Mar 31, 2012 10-Q 2012-05-03
Q4 2011 42.7M +379K +0.89% Dec 31, 2011 10-K 2013-02-19
Q3 2011 42.7M +528K +1.25% Sep 30, 2011 10-Q 2011-11-03
Q2 2011 42.7M +557K +1.32% Jun 30, 2011 10-Q 2011-08-03
Q1 2011 42.4M Mar 31, 2011 10-Q 2011-05-05
Q4 2010 42.3M Dec 31, 2010 10-K 2012-02-13
Q3 2010 42.2M Sep 30, 2010 10-Q 2010-11-04
Q2 2010 42.1M Jun 30, 2010 10-Q 2010-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.